Apex Critical Metals Lifts C$10M via LIFE Placement to Fund Three-Project Exploration Push

The Canadian critical minerals explorer is tapping the equity markets again, structuring a brokered private placement under the Listed Issuer Financing Exemption (LIFE) that could bring in gross proceeds of up to C$10,001,600. Apex Critical Metals will use the capital to advance its three core projects — Rift, CAP and Lac Le Moyne — while also shoring up working capital for ongoing operations.

Unit Offering Details

Apex plans to issue up to 5,264,000 units at C$1.90 per unit. Each unit consists of one common share and one warrant. The warrant entitles the holder to purchase an additional common share at C$2.60 for 24 months after the closing of the placement. This structure gives the company a potential second round of funding if the share price makes exercise economically attractive down the line.

The placement is being led by Canaccord Genuity Corp. as lead agent. A syndicate of brokers will also be involved. They receive a cash commission equal to 6% of gross proceeds, as well as compensation warrants totaling 3% of the number of units sold. Such terms are standard in the junior mining space but dilute existing shareholders in the process.

An over-allotment option allows the agents to increase the size of the placement by up to 789,600 additional units. If fully exercised, that would bring in roughly another C$1,500,240, pushing the total gross proceeds past C$11.5 million.

Should investors sell immediately? Or is it worth buying Apex Critical Metals?

Deployment Across the Pipeline

The funds are earmarked for systematic exploration work across Apex's three flagship projects. Rift, CAP and Lac Le Moyne will each receive a share of the capital, though the company has not specified an allocation breakdown. A portion will also flow into general working capital — a critical buffer given the ongoing costs of drilling programs, geological evaluations and permitting that can quickly tie up liquidity at an explorer.

Apex's multi-asset strategy for critical minerals — the rare earths, niobium and other technology-facing commodities — remains intact. Fresh capital buys time, drill metres and assay results, but it does not yet constitute a resource. The real test will come when the company translates that spending into measurable geological progress.

Market Response and Timing

The stock has shown resilience over the past year, trading at EUR 1.34 on the day of the announcement, up 2.61% in the session. On a twelve-month view, the gain stands at 157.92%. That kind of recovery reflects the operational optimism surrounding Apex, but the repeated need to tap equity markets before any revenue stream materialises is a persistent overhang.

Apex Critical Metals at a turning point? This analysis reveals what investors need to know now.

The placement is scheduled to close in June 2026, subject to standard conditions including regulatory approval. A key attribute of the LIFE structure: the securities issued will generally not be subject to a hold period in Canada, meaning they can be traded immediately after closing. That ensures liquidity for investors who participate, but also prevents any forced lock-up that could hamper price discovery.

For now, Apex has bought itself financial breathing room. The next milestone will be whether the additional spending on Rift, CAP and Lac Le Moyne yields results that justify the dilution.

Ad

Apex Critical Metals Stock: New Analysis - 19 May

Fresh Apex Critical Metals information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Apex Critical Metals analysis...

en | CA03753D1042 | APEX | boerse | 69374385 |